Physician profile
William B Teague
NPI 1942457775
$3,280.88
in general payments reported to CMS, 2019-2025
15 companies · $663 in 2025
The $663 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $171 · 2021: $210 · 2022: $610 · 2023: $566 · 2024: $469 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,518 · Entertainment: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,517.94 |
| Entertainment | $180.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,017.56 | 2019-2025 | Precision7, Total30, Precision 7 |
| Johnson & Johnson Vision Care, INC. | $536.70 | 2019-2024 | Acuvue |
| Oyster Point Pharma, INC. | $315.07 | 2022-2025 | Tyrvaya |
| Bausch & Lomb Americas INC. | $295.64 | 2022-2025 | Miebo, Infuse |
| Optos, INC. | $283.44 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Tarsus Pharmaceuticals, INC. | $188.86 | 2024 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $141.74 | 2019 | |
| Sun Pharmaceutical Industries INC. | $131.31 | 2022-2025 | Cequa |
| Shire North American Group INC | $121.10 | 2019 | |
| Glaukos Corporation | $99.26 | 2022-2025 | Photrexa Viscous and Photrexa |
| Coopervision INC. | $60.79 | 2025 | Misight Contact Lens |
| Ani Pharmaceuticals, INC. | $32.37 | 2023 | Purified Cortrophin Gel |
| Carl Zeiss Meditec USA, INC. | $25.55 | 2025 | Cirrus Hd-Oct |
| Allergan, INC. | $22.62 | 2021 | |
| Abb Con-Cise Optical Group LLC | $8.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Teague listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.